Navigation Links
Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
Date:11/15/2012

Putnam Valley, NY. (Nov. 15, 2012) Researchers in Taiwan have developed a "safe, feasible and robust co-culture system" supplied by human umbilical cord mensenchymal stem cells (HUCMSCs) to feed the sustained culture used for human embryonic stem cell (hESC) expansion prior to cell transplantation. The co-culture, said the researchers, "appears to eliminate the most feared characteristic of transplanted hESCs," which is their propensity to form tumors.

The study, published in the current issue of CELL TRANSPLANTATION, is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/.

"Embryonic stem cells have pluripotent potential," said study co-author Dr. Tang-Yuan Chu of the Buddhist Tzu Chi General Hospital at Tzu Chi University in Hualien, Taiwan. "The sustained maintenance of hESCs depends on a co-culture with an animal based "feeder" that can create the risk for transmitting nonhuman materials and unknown pathogens. To solve this problem, human tissues have been used as feeders."

The expansion of pluripotent hESCs traditionally requires a feeder culture, meaning that a variety of animal and human tissues have been used in feeder cultures.

The researchers note that while hESCs have been successfully co-cultured using human fetal muscle and skin cells, adult fallopian tube epithelial cells, foreskin cells, and bone marrow stem cells, their study used hUCMScs to create a co-culture. They said that using hUCMSCs as a source feeder has several advantages, including their wide availability, ease of handling and low immunogenicity.

However, according to the researchers, when using various mouse or primate tissues, and even when using human tissues for co-cultures, tumor-like formations called "teratomas" - growths containing tissues belonging to all three germ layers - often form. Although undesirable, teratomas have been used as a marker for the ability of stem cells to be able to develop pluripotency.

This study demonstrated that pluripotency development need not necessarily be teratoma forming.

"We suggest that the feeder we developed from hUCMSCs may support the transition of hESCs that does not grow teratomas because, unlike tissue sources for other feeders, by using hUCMSCs we did not use material comprised of all three germ layers," said the researchers.

"In addition to eliminating teratomas, the proposed system also significantly reduces the workload involved in the preparation of new feeder lines," they concluded.


'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related medicine news :

1. Sociology, economics researchers receive grant to study development across the human lifespan
2. Gut Bacteria Often Similar in Humans, Chimps: Study
3. First trial in humans of minicells: A completely new way of delivering anti-cancer drugs
4. Testing pain killers on humans could save money and speed the arrival of new drugs
5. New, improved mouse model of human Alzheimers may enable drug discovery
6. Spread of human melanoma cells in mice correlates with clinical outcomes in patients
7. First gene therapy study in human salivary gland shows promise
8. Clinical trials for first-ever human hookworm vaccine advance
9. Bigger human genome pool uncovers rarer variants
10. A Viagra follow-up? Drug used to treat glaucoma actually grows human hair
11. Genes of Africas Khoe-San Peoples Give Clues to Human Evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... named one of Michigan’s 2017 Best and Brightest in Wellness® by Best and ... Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Calif. , Oct. 11, 2017  BioPharmX Corporation ... scientific team that developed an innovative way to use ... of the delivery of new drugs. ... Fall Clinical Dermatology Conference will show how researchers from ... Hospital, Harvard Medical School used a suite of imaging ...
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
Breaking Medicine Technology: